References

Leucocytes and Th-associated cytokine profile of HIV-leishmaniasis co-infected persons attending Abuja Teaching Hospital, Nigeria

10.5152/eurasianjmed.2020.20008 · 2020 · External reference

Concordance of cancer-associated cytokines and mitochondrial DNA deletions in individuals with hepatocellular carcinoma and people living with HIV in ghana

10.1186/s12876-025-04399-5 · 2025 · External reference

Safety and efficacy of immune checkpoint inhibitors in human immunodeficiency virus-associated cancer: a systematic scoping review

10.3390/diseases13080230 · 2025 · External reference

Antitumorigenic action of nelfinavir: effects on multiple myeloma and hematologic malignancies (review)

10.3892/or.2020.7562 · 2020 · External reference

Harnessing natural killer cell innate and adaptive traits in HIV infection

10.3389/fcimb.2020.00395 · 2020 · External reference

Rad18 suppresses the late step of human immunodeficiency virus type 1 replication

10.1101/2025.11.26.690725 · 2025 · External reference

Spectrum of malignancies among human immunodeficiency virus-infected patients at a tertiary level human immunodeficiency virus-anti-retroviral therapy center in a North Indian hospital

10.4103/ijstd.ijstd_28_19 · 2021 · External reference

Human immunodeficiency virus type 1 Vpr mediates degradation of APC1, a scaffolding component of the anaphase-promoting complex/cyclosome

10.1128/jvi.00971-20 · 2021 · External reference

HIV/AIDS associated lymphoma: review

10.2147/blctt.s361320 · 2022 · External reference

A comparison of lung cancer in HIV-positive and HIV-negative populations

10.7196/ajtccm.2022.v28i2.162 · 2022 · External reference

New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature

10.26355/eurrev_202305_32328 · 2023 · External reference

The role of liver macrophages in viral liver pathogenesis

10.1093/jleuko/qiaf088 · 2025 · External reference

Human immunodeficiency virus infection promotes human papillomavirus-mediated anal squamous carcinogenesis: an immunologic and pathobiologic review

10.1159/000518758 · 2022 · External reference

Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display

10.1039/d2bm01132h · 2023 · External reference

Increased human herpesvirus-8 neutralizing response during remission from Kaposi's sarcoma

10.1099/jgv.0.002044 · 2024 · External reference

CD4/CD8 ratio and the risk of Kaposi sarcoma or non-hodgkin lymphoma in the context of efficiently treated human immunodeficiency virus (HIV) infection: a collaborative analysis of 20 European cohort studies

10.1093/cid/ciaa1137 · 2021 · External reference

Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells

10.1073/pnas.0408192102 · 2005 · External reference

HIV-1 nef counteracts autophagy restriction by enhancing the association between BECN1 and its inhibitor BCL2 in a PRKN-dependent manner

10.1080/15548627.2020.1725401 · 2021 · External reference

HIV-1 nef interacts with the cyclin K/CDK13 complex to antagonize SERINC5 for optimal viral infectivity

10.1016/j.celrep.2021.109514 · 2021 · External reference

Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis

10.1136/jitc-2022-004564 · 2022 · External reference

A novel prognostic score including the CD4/CD8 for AIDS-related lymphoma

10.3389/fcimb.2022.919446 · 2022 · External reference

Single-cell analysis of residual esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy reveals TFAM-mediated immunoregulation in dendritic cells

10.1158/0008-5472.can-25-4738 · 2026 · External reference

Human immunodeficiency virus-associated exosomes promote Kaposi's sarcoma-associated herpesvirus infection via the epidermal growth factor receptor

10.1128/jvi.01782-19 · 2020 · External reference

Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling

10.18632/oncotarget.9221 · 2016 · External reference

PD-1/PD-L1 blockade in HIV-associated advanced lung cancer: from mechanisms to clinical practice

10.3389/fimmu.2026.1708278 · 2026 · External reference

Tubular-specific expression of HIV protein Vpr leads to severe tubulointerstitial damage accompanied by progressive fibrosis and cystic development

10.1016/j.kint.2022.12.012 · 2023 · External reference

Effect of innate and adaptive immune mechanisms on treatment regimens in an AIDS-related Kaposi's sarcoma model

10.1080/17513758.2021.1912420 · 2021 · External reference

False-reactive fourth-generation human immunodeficiency virus testing in cancer patients

10.1093/cid/ciad608 · 2024 · External reference

Expression of programmed death-ligand 1 and programmed cell death-1 across the anal neoplasia disease continuum and association with survival in anal cancer

10.1016/j.modpat.2025.100918 · 2026 · External reference

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

10.1073/pnas.2020459118 · 2021 · External reference

Viral bad news sent by EVAIL

10.3390/v13061168 · 2021 · External reference

HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses

10.1016/j.chom.2021.01.006 · 2021 · External reference

Outcomes of AIDS-associated Kaposi sarcoma in mozambique after treatment with pegylated liposomal doxorubicin

10.1186/s13027-020-00341-4 · 2021 · External reference

Clinicopathological features and mortality in patients with kaposi sarcoma and HIV: a retrospective analysis of a thirty-year study from a peruvian oncologic center

10.1200/go.21.00379 · 2022 · External reference

Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study

10.1080/1120009x.2021.1920248 · 2021 · External reference

Effects of HIV on the tumor microenvironment

10.1007/978-3-030-44518-8_4 · 2020 · External reference

Pathways towards human immunodeficiency virus elimination

10.1016/j.ebiom.2020.102667 · 2020 · External reference

Clinical and molecular properties of human immunodeficiency virus-related diffuse large b-cell lymphoma

10.3389/fonc.2021.675353 · 2021 · External reference

The role of autophagy in HIV infection and immunological recovery of ART-treated PLWH

10.3390/v17070884 · 2025 · External reference

Genetic determinants of lung cancer: understanding the oncogenic potential of somatic missense mutations

10.1016/j.ygeno.2022.110401 · 2022 · External reference

Incomplete immune reconstitution and traditional Chinese medicine in patients with HIV/AIDS: challenges and perspectives

10.2147/idr.s497083 · 2024 · External reference

The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma

10.1002/hep.32740 · 2023 · External reference

Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination

10.1186/s12967-020-02478-7 · 2020 · External reference

Potential role of tumor-associated macrophages and CD163/CD68 ratio in mycosis fungoides and sézary syndrome in correlation with serum sCD163 and CCL22

10.1111/cup.14155 · 2022 · External reference

Anal cancer: emerging standards in a rare disease

10.1200/jco.21.02566 · 2022 · External reference

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

10.1038/345084a0 · 1990 · External reference

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

10.1038/371674a0 · 1994 · External reference

The role of microbial translocation and immune activation in AIDS-associated non-hodgkin lymphoma pathogenesis: what have we learned?

10.1615/critrevimmunol.2020033319 · 2020 · External reference

A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer

10.1002/ijc.34143 · 2022 · External reference

High expression of HIV-1 matrix protein p17 in both lymphoma and lymph node tissues of AIDS patients

10.1016/j.prp.2022.154061 · 2022 · External reference

Exploiting manipulated small extracellular vesicles to subvert immunosuppression at the tumor microenvironment through mannose receptor/CD206 targeting

10.3390/ijms21176318 · 2020 · External reference

Lung cancer (LC) in HIV positive patients: pathogenic features and implications for treatment

10.3390/ijms21051601 · 2020 · External reference

Plasmablastic lymphoma associated with adjacent mature plasma cell population exhibiting opposite light chain restriction

10.1155/2020/8875547 · 2020 · External reference

Prognostic divergence in human immunodeficiency virus/hepatitis B virus versus hepatitis B virus-associated hepatocellular carcinoma after resection: intrahepatic pre-S deletions mutants and T-cell depletion under viral suppression

10.1093/infdis/jiaf433 · 2025 · External reference

The Nef protein of themacrophage tropicHIV-1 strain AD8 counteracts human BST-2/tetherin

10.3390/v12040459 · 2020 · External reference

The FKBP51s splice isoform predicts unfavorable prognosis in patients with glioblastoma

10.1158/2767-9764.crc-24-0083 · 2024 · External reference

Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines

10.1016/j.chom.2011.09.012 · 2011 · External reference

A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma

10.1038/s41418-024-01432-0 · 2025 · External reference

Safety and tolerability of carboplatin and paclitaxel in cancer patients with HIV (AMC-078), an AIDS malignancy consortium (AMC) study

10.1093/oncolo/oyac004 · 2022 · External reference

Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in tigray, Northern Ethiopia

10.1186/s12879-021-06206-4 · 2021 · External reference

New hope and promise with CRISPR-Cas9 technology for the treatment of HIV

10.1007/s10142-025-01613-1 · 2025 · External reference

Identifying specific Notch1 target proteins in lung carcinoma cells

10.14670/hh-18-271 · 2021 · External reference

[Diagnosis and treatment of HIV-associated lymphoma: Update 202]

10.1055/a-1169-0848 · 2021 · External reference

Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life west-european cohort: implications for adjuvant therapy

10.1016/j.ejca.2022.12.010 · 2023 · External reference

A tissue virus microenvironment with activated stress responses underlies durable SIV persistence

10.64898/2026.04.02.716177 · 2026 · External reference

Gastrointestinal Kaposi sarcoma without dermatological lesions: a case report

10.12659/ajcr.941815 · 2023 · External reference

Oncogenic effects of HIV-1 proteins, mechanisms behind

10.3390/cancers13020305 · 2021 · External reference

Prospects for liquid biopsy approaches in lymphomas

10.1080/10428194.2024.2389210 · 2024 · External reference

HIV tat protein induces myocardial fibrosis through TGF-β1-CTGF signaling cascade: a potential mechanism of HIV infection-related cardiac manifestations

10.1007/s12012-021-09687-6 · 2021 · External reference

Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2hi macrophages in infarcted hearts

10.1038/s41467-022-32284-2 · 2022 · External reference

Immunovirological discordance among people living with human immunodeficiency virus at a center in Western India: a retrospective study

10.4103/ijstd.ijstd_121_22 · 2023 · External reference

HIV versus the human body: a case report of an immunity-compromised patient

10.7759/cureus.62942 · 2024 · External reference

Lymphoma driver mutations at the root of somatic evolution of nerve-damaging autoantibodies in myelin associated glycoprotein neuropathy

10.1016/j.jaut.2025.103474 · 2025 · External reference

Cancer immunotherapy in adult patients with HIV

10.1136/jim-2021-002205 · 2022 · External reference

Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV

10.1007/s12072-024-10768-1 · 2025 · External reference

Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma

10.1038/s41598-020-80311-3 · 2021 · External reference

Complications of untreated advanced HIV/AIDS with Kaposi sarcoma in a young African American male: a case report

10.7759/cureus.69449 · 2024 · External reference

Dyspnea in an HIV patient: a not so typical presentation of lung adenocarcinoma

10.1177/2324709620927872 · 2020 · External reference

Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma

10.1371/journal.ppat.1011581 · 2023 · External reference

NLRP3 disturbs Treg/Th17 cell balance to aggravate apical periodontitis

10.1177/00220345231151692 · 2023 · External reference

HIV Vpr modulates the host DNA damage response at two independent steps to damage DNA and repress double-strand DNA break repair

10.1128/mbio.00940-20 · 2020 · External reference

Depletion of plasmacytoid dendritic cells rescues HIV-reactive stem-like CD8 + T cells during chronic HIV-1 infection

10.1126/scitranslmed.adr3930 · 2025 · External reference

Expanding the boundaries for liver transplantation for hepatocellular carcinoma

10.1016/j.suc.2023.08.006 · 2024 · External reference

Impact of HIV-1 Tat on FDFT1 suppression, changes in cholesterol level, and KSHV replication in BCBL1 cells

10.2174/011570162x371221250630105858 · 2025 · External reference

HIV-associated lymphomas: updates from pathogenesis to treatment strategies

10.2174/011570162x367092250901062629 · 2026 · External reference

Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV-infected patients on antiretroviral therapy

10.1002/jmv.28559 · 2023 · External reference

Retrospective analysis of patients with hepatocellular carcinoma complicated with human immunodeficiency virus infection after hepatectomy

10.4251/wjgo.v16.i9.3851 · 2024 · External reference

Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection

10.1111/apt.17654 · 2023 · External reference

Use of pembrolizumab with or without pomalidomide in HIV-associated non-hodgkin's lymphoma

10.1136/jitc-2020-002097 · 2021 · External reference

The role of viruses in HIV-associated lymphomas

10.1053/j.seminhematol.2022.11.002 · 2022 · External reference

HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and epstein-barr virus

10.1128/cmr.00022-23 · 2024 · External reference

The course of kaposi's sarcoma, a marker disease for the initial diagnosis of AIDS, under ongoing cART

10.3233/ch-209203 · 2020 · External reference

Disseminated kaposi sarcoma

10.2147/ccid.s376060 · 2022 · External reference

Geospatial access to CAR-t clinical trials for non-hodgkin lymphoma for persons with HIV

10.1001/jamanetworkopen.2026.14265 · 2026 · External reference

Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles

10.1371/journal.ppat.1011725 · 2023 · External reference

Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV

10.1186/s12876-020-01372-2 · 2020 · External reference

Compartmentalized T cell profile in the lungs of patients with HIV-1-associated pulmonary Kaposi sarcoma

10.1097/md.0000000000028328 · 2021 · External reference

Identification of viral protein R of human immunodeficiency virus-1 (HIV) and interleukin-6 as risk factors for malignancies in HIV-infected individuals: a cohort study

10.1371/journal.pone.0296502 · 2024 · External reference

Hickam's dictum prevails: Kaposi sarcoma and primary effusion lymphoma in a person living with human immunodeficiency virus (HIV) and human herpesvirus 8 (HHV-8) infection

10.7759/cureus.78081 · 2025 · External reference

IFNL4 genotype does not associate with CD4 T-cell recovery in people living with human immunodeficiency virus

10.1089/aid.2020.0104 · 2021 · External reference

Safety and effectiveness of Yttrium-90 radioembolization in people living with human immunodeficiency virus

10.1016/j.jvir.2024.12.596 · 2025 · External reference

Screening for hepatocellular carcinoma in HIV-infected patients: current evidence and controversies

10.1007/s11904-019-00475-0 · 2020 · External reference

Decoding HIV-1 next move through matrix protein p17 Quasi-Species

10.1002/mbo3.70280 · 2026 · External reference

Activation of CXCR3 + Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development

10.1128/jvi.01532-24 · 2025 · External reference

Anoikis-related gene signatures can aid prognosis of lung adenocarcinoma

10.17219/acem/171482 · 2024 · External reference

Alterations in circulating immunoregulatory proteins discriminate poor CD4 T lymphocyte trajectories in people with HIV on suppressive antiretroviral therapy

10.1128/mbio.02265-24 · 2024 · External reference

Innate immune dysfunction and persistent activation in South African HIV Elite Controllers

10.3389/fimmu.2025.1603436 · 2025 · External reference

Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi sarcoma and is regulated by KSHV vFLIP

10.1371/journal.ppat.1011881 · 2024 · External reference

Cancer spectrum in HIV-infected patients: a zonal hospital experience in Tanzania

10.1016/j.ctarc.2020.100213 · 2020 · External reference

Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells

10.1371/journal.ppat.1010673 · 2022 · External reference

Evaluating the safety and efficacy of PD-1 inhibitors in HIV patients diagnosed with lung cancer: a systematic review

10.3390/ph18111654 · 2025 · External reference

Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of kaposi sarcoma in adults

10.3389/fimmu.2023.1216480 · 2023 · External reference

Applications of nanoparticles for herpes simplex virus (HSV) and human immunodeficiency virus (HIV) treatment

10.1166/jbn.2021.3074 · 2021 · External reference

A follicular regulatory innate lymphoid cell population impairs interactions between germinal center Tfh and B cells

10.1038/s42003-021-02079-0 · 2021 · External reference

Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer

10.1039/d3mo00025g · 2023 · External reference

Kaposi's sarcoma in virally suppressed people living with HIV: an emerging condition

10.3390/cancers13225702 · 2021 · External reference

Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection

10.3748/wjg.v32.i3.114176 · 2026 · External reference

Survival of patients living with HIV and cancer in Cali, Colombia

10.25100/cm.v54i3.5558 · 2023 · External reference

The rapid CD4 + T-lymphocyte decline and human immunodeficiency virus progression in females compared to males

10.1038/s41598-020-73852-0 · 2020 · External reference

MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry

10.1111/his.14336 · 2021 · External reference

Macrophages in colorectal cancer: from normal mucosa to distant metastasis: beyond the M1/M2 paradigm

10.7150/jca.126772 · 2026 · External reference

Anal dysplasia screening in people living with HIV: long-term follow-up in a large cohort from Northwest Spain

10.1089/apc.2023.0231 · 2024 · External reference

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

10.1016/j.jhepr.2023.100741 · 2023 · External reference

Revisiting the use of steroids in oncology

10.1007/s12032-025-03214-1 · 2025 · External reference

Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy

10.1097/qad.0000000000003048 · 2021 · External reference

HIV-1-mediated acceleration of oncovirus-related non-AIDS-defining cancers

10.3390/biomedicines10040768 · 2022 · External reference

HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling

10.1186/s12967-024-05489-w · 2024 · External reference

HIV protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction

10.1158/1535-7163.mct-20-0055 · 2020 · External reference

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS malignancy consortium 095 study

10.1002/cncr.35110 · 2024 · External reference

Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis

10.1016/j.imlet.2013.05.003 · 2013 · External reference

Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study

10.1016/j.ijid.2021.12.338 · 2022 · External reference

Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in burkitt lymphoma

10.1111/bjh.17083 · 2021 · External reference

10.1371/journal.ppat.1013087 · 2025 · Admitted local publication

Pre-existing tumor host immunity characterization in resected non-small cell lung cancer

10.1016/j.lungcan.2023.107257 · 2023 · External reference

Antiviral drugs in HIV and cardiovascular disease: mechanistic insights and clinical implications

10.3390/ph19020205 · 2026 · External reference

10.1002/deo2.70256 · 2026 · Admitted local publication

Zinc finger protein 598 promotes HIV-1 replication and latent reactivation by stabilizing the expression of viral trans-activator of transcription tat

10.1016/j.ijbiomac.2026.151322 · 2026 · External reference

Immunology of EBV-related lymphoproliferative disease in HIV-positive individuals

10.3389/fonc.2020.01723 · 2020 · External reference

HIV-1 tat is present in the serum of people living with HIV-1 despite viral suppression

10.1016/j.ijid.2024.106994 · 2024 · External reference

Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV

10.1097/qad.0000000000002653 · 2020 · External reference

Timing of antiretroviral therapy initiation and risk of cancer among persons living with human immunodeficiency virus

10.1093/cid/ciaa1046 · 2021 · External reference

HIV integration into the PTEN gene and its tumor microenvironment implications for lung cancer

10.3390/curroncol32070389 · 2025 · External reference

Presentation, treatment and long-term outcomes of hepatocellular carcinoma in patients with and without HIV: a comparative observational cohort study

10.1016/j.hpb.2025.02.012 · 2025 · External reference

Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy

10.4103/ijo.ijo_1070_20 · 2020 · External reference

Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

10.1038/s41467-021-24386-0 · 2021 · External reference

People living with HIV co-infected with the kaposi sarcoma-associated herpes virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma

10.1002/jmv.29840 · 2024 · External reference

Nationwide longitudinal annual survey of HIV/AIDS referral hospitals in japan from 1999 to 2021: trend in non-AIDS-defining cancers among individuals infected with HIV-1

10.1097/qai.0000000000003389 · 2024 · External reference

Real-world experiences of CAR T-cell therapy for large B-cell lymphoma: how similar are they to the prospective studies?

10.36401/jipo-21-2 · 2021 · External reference

HIV TAT-mediated microglial senescence: role of SIRT3-dependent mitochondrial oxidative stress

10.1016/j.redox.2020.101843 · 2021 · External reference

The complex dysregulations of CD4 T cell subtypes in HIV infection

10.3390/ijms25147512 · 2024 · External reference

Applications of cell therapy in the treatment of virus-associated cancers

10.1038/s41571-024-00930-x · 2024 · External reference

Retrotransposition and senescence in mouse heart tissue by viral protein R of human immunodeficiency virus-1

10.1016/j.yexmp.2020.104433 · 2020 · External reference

Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk

10.1093/cid/ciaf595 · 2026 · External reference

Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV

10.1093/cid/ciaf635 · 2026 · External reference

TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells

10.1097/qad.0000000000002488 · 2020 · External reference

Addressing barriers to care in hepatocellular carcinoma: promoting equity and access

10.7759/cureus.41893 · 2023 · External reference

Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia

10.1093/cid/ciad654 · 2024 · External reference

Hepatocellular carcinoma in hepatitis B and human immunodeficiency virus coinfection in Africa: a focus on surveillance

10.20517/2394-5079.2022.32 · 2022 · External reference

Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection

10.1073/pnas.1318175111 · 2014 · External reference

Dendritic cell biology and its role in tumor immunotherapy

10.1186/s13045-020-00939-6 · 2020 · External reference

Landscape of gut mucosal immune cells showed gap of follicular or memory B cells into plasma cells in immunological non-responders

10.1002/ctm2.1699 · 2024 · External reference

Evaluation of human herpesvirus-8 viremia and antibody positivity in patients with HIV infection with human herpesvirus-8-related diseases

10.1002/jmv.29324 · 2023 · External reference

Kaposi's sarcoma-associated herpesvirus viral protein kinase augments cell survival

10.1038/s41419-023-06193-1 · 2023 · External reference

A retrospective study of Kaposi's sarcoma in Hotan region of Xinjiang, China

10.1097/md.0000000000035552 · 2023 · External reference

Transcriptomic profiling and tumor microenvironment classification reveal unique and dynamic immune biology in HIV-associated kaposi sarcoma

10.3390/cells14020134 · 2025 · External reference

HIV-1 tat mediates microglial NLRP3 inflammasome activation and neurotoxicity by inducing cytosolic mtDNA stress

10.1016/j.ijbiomac.2025.145093 · 2025 · External reference

The impact of HIV-1 Nef on CD4 + T cells

10.1080/10409238.2025.2599773 · 2026 · External reference

HIV proviral DNA integration can drive T cell growth ex vivo

10.1073/pnas.2013194117 · 2020 · External reference

[Expression of HIV-1 reverse transcriptase in murine cancer cells increases mitochondrial respiration]

10.1134/s0026893322050168 · 2022 · External reference

Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders

10.1097/cm9.0000000000002493 · 2023 · External reference

Hexokinase HK3-mediated o-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC

10.1038/s41419-024-06921-1 · 2024 · External reference

Plasma proteomic analysis reveals altered protein abundances in HIV/HBV co-infection individuals with HCC and with liver cirrhosis

10.1038/s41598-025-99072-y · 2025 · External reference

A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study

10.1186/s12885-022-09433-3 · 2022 · External reference

Evolutionary plasticity of SH3 domain binding by nef proteins of the HIV-1/SIVcpz lentiviral lineage

10.1371/journal.ppat.1009728 · 2021 · External reference

Gut microbiota-derived indole-3-lactic acid suppresses anti-PD-1 efficacy in esophageal squamous cell carcinoma

10.1016/j.chom.2026.02.019 · 2026 · External reference

High baseline body mass index predicts recovery of CD4+ T lymphocytes for HIV/AIDS patients receiving long-term antiviral therapy

10.1371/journal.pone.0279731 · 2022 · External reference

TREM2 in cardiovascular diseases: mechanisms and therapeutic perspectives

10.1016/j.arr.2025.102774 · 2025 · External reference